BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22237710)

  • 1. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
    Barresi V; Leni A; Tuccari G; Barresi G
    Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) immunoexpression in follicular-patterned lesions of the thyroid gland.
    Barresi V; Vitarelli E; Reggiani Bonetti L; Tuccari G; Barresi G
    Virchows Arch; 2012 Mar; 460(3):319-25. PubMed ID: 22371224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
    Saleh HA; Jin B; Barnwell J; Alzohaili O
    Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination.
    Ma H; Xu S; Yan J; Zhang C; Qin S; Wang X; Li N
    Pol J Pathol; 2014 Oct; 65(3):202-9. PubMed ID: 25372417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
    Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.
    Slosar M; Vohra P; Prasad M; Fischer A; Quinlan R; Khan A
    Endocr Pathol; 2009; 20(3):149-57. PubMed ID: 19449140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade.
    Barresi V; Ieni A; Bolignano D; Magno C; Buemi M; Barresi G
    Oncol Rep; 2010 Aug; 24(2):305-10. PubMed ID: 20596614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
    Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
    Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
    Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
    Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.
    Bolignano D; Donato V; Lacquaniti A; Fazio MR; Bono C; Coppolino G; Buemi M
    Cancer Lett; 2010 Feb; 288(1):10-6. PubMed ID: 19540040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.